Список литературы
Локализованная склеродермия. Клинические рекомендации РОДВК. М., 2020.
Потекаев Н.С., Плиева А.Р., Тепалюк Н.П., Сергеев Ю.Ю. Полиморфный вариант склератрофического лихена // Клиническая дерматология и венерология. 2014. № 2. С. 35–40.
Aranegui B., Jiménez-Reyes J. Morphea in childhood: an update // Actas Dermosifiliogr. 2018. Vol. 109. N. 4. P. 312–322.
Bielsa Marsol I. Update on the classification and treatment of localized scleroderma // Actas Dermosifiliogr. 2013. Vol. 104. N. 8. P. 654–666.
Careta M.F. Romiti R. Localized scleroderma: clinical spectrum and therapeutic update // An. Bras. Dermatol. 2015. Vol. 90. N. 1. P. 62–73.
Distler O., Cozzio A. Systemic sclerosis and localized scleroderma — current concepts and novel targets for therapy // Semin. Immunopathol. 2016. Vol. 38. N. 1. P. 87–95.
Fett N., Werth V.P. Update on morphea: part I. Epidemiology, clinical presentation, and pathogenesis // J. Am. Acad. Dermatol. 2011. Vol. 64. N. 2. P. 217–228.
Graham P.M., Gupta N., Altman D.A. En coup de sabre // Cutis. 2019. Vol. 103. N. 1. P. 34–36.
Kim D.H., Lee K.R., Kim T.Y., Yoon M.S. Coexistence of lichen sclerosus with morphoea showing bilateral symmetry // Clin. Exp. Dermatol. 2009. Vol. 34. N. 7. P. 416–418.
Kreuter A. Localized scleroderma // Dermatol. Ther. 2012. Vol. 25. N. 2. P. 135–147.
Kreuter A., Krieg T., Worm M. et al. [AWMF Guideline No. 013/066. Diagnosis and therapy of circumscribed scleroderma] // J. Dtsch. Dermatol. Ges. 2009. Vol. 7. Suppl. 6. P. 1–14. (In German).
Kreuter A., Kryvosheyeva Y., Terras S. et al. Association of autoimmune diseases with lichen sclerosus in 532 male and female patients // Acta Derm. Venereol. 2013. Vol. 93. N. 2. P. 238–241.
Laxer R.M., Zulian F. Localized scleroderma // Curr. Opin. Rheumatol. 2006. Vol. 18. N. 6. P. 606–613.
Leitenberger J.J., Cayce R.L., Haley R.W. et al. Distinct autoimmune syndromes in morphea: a review of 245 adult and pediatric cases // Arch. Dermatol. 2009. Vol. 145. N. 5. P. 545–550.
Lutz V., Francés C., Bessis D. et al. High frequency of genital lichen sclerosus in a prospective series of 76 patients with morphea: toward a better understanding of the spectrum of morphea // Arch. Dermatol. 2012. Vol. 148. N. 1. P. 24–28.
Mertens J.S., Seyger M.M.B., Thurlings R.M. et al. Morphea and eosinophilic fasciitis: an update // Am. J. Clin. Dermatol. 2017. Vol. 18. N. 4. P. 491–512.
Moinzadeh P., Kreuter A., Krieg T., Hunzelmann N. Morphea/lokalisierte Sklerodermie und extragenitaler Lichen sclerosus [Morphea or localized scleroderma and extragenital lichen sclerosus] // Hautarzt. 2018. Vol. 69. N. 11. P. 892–900. (In German).
Pope E., Laxer R.M. Diagnosis and management of morphea and lichen sclerosus and atrophicus in children // Pediatr. Clin. North Am. 2014. Vol. 61. N. 2. P. 309–319.
Promm M., Rösch W.H., Kirtschig G. Lichen sclerosus im Kindesalter [Lichen sclerosus in children] // Urologe A. 2020. Vol. 59. N. 3. P. 271–277. (In German).
Succaria F., Kurban M., Kibbi A., Abbas O. Clinicopathological study of 81 cases of localized and systemic scleroderma // J. Eur. Acad. Dermatol. Venereol. 2013. Vol. 27. N. 2. P. 191–197.
Zinchuk A.N., Kalyuzhna L.D., Pasichna I.A. Is localized scleroderma caused by Borrelia burgdorferi? // Vector Borne Zoonotic Dis. 2016. Vol. 16. N. 9. P. 577–580.
&hide_Cookie=yes)